Literature DB >> 8298330

Progressive visual deterioration leading to blindness after pediatric heart transplantation.

K O Schowengerdt1, R J Gajarski, S Denfield.   

Abstract

We present the case of a 10-year-old girl who developed visual loss progressing to blindness after orthotopic heart transplantation and an immunosuppressive regimen of cyclosporine, azathioprine, and prednisone. Headaches and visual deterioration began 2 months after transplantation, and a diagnosis of pseudotumor cerebri was made. The patient's visual loss continued despite aggressive medical and surgical therapy, which included bilateral optic nerve sheath fenestration. To our knowledge, permanent visual loss as a late sequela following pediatric heart transplantation and immunosuppressive therapy has not been reported previously in the English literature. Although the cause of visual loss after transplantation in our patient is poorly understood, we conclude that permanent visual loss, although rare, should be considered as a possible late neurologic sequela after pediatric heart transplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298330      PMCID: PMC325116     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  18 in total

1.  A system for grading cardiac allograft rejection.

Authors:  H A McAllister; M J Schnee; B Radovancević; O H Frazier
Journal:  Tex Heart Inst J       Date:  1986-03

2.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

Authors:  M E Billingham; N R Cary; M E Hammond; J Kemnitz; C Marboe; H A McCallister; D C Snovar; G L Winters; A Zerbe
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

Review 3.  Neurologic complications related to cardiac surgery.

Authors:  A J Furlan; C A Sila; M I Chimowitz; S C Jones
Journal:  Neurol Clin       Date:  1992-02       Impact factor: 3.806

4.  Cyclosporin neurotoxicity in cardiac transplant recipients.

Authors:  R J Lane; S W Roche; A A Leung; A Greco; L S Lange
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

5.  Cyclosporine-associated central-nervous-system toxicity after allogeneic bone-marrow transplantation.

Authors:  K Atkinson; J Biggs; P Darveniza; J Boland; A Concannon; A Dodds
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

Review 6.  Neurologic complications of cardiac transplantation.

Authors:  J R Hotson; D R Enzmann
Journal:  Neurol Clin       Date:  1988-05       Impact factor: 3.806

Review 7.  Cortical blindness: a rare complication of cyclosporine therapy.

Authors:  R Ghalie; W E Fitzsimmons; D Bennett; H Kaizer
Journal:  Bone Marrow Transplant       Date:  1990-08       Impact factor: 5.483

8.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

9.  Ophthalmic complications after heart transplantation.

Authors:  M F Quinlan; J F Salmon
Journal:  J Heart Lung Transplant       Date:  1993 Mar-Apr       Impact factor: 10.247

10.  Neurologic complications of heart transplantation in children.

Authors:  A B Martin; J T Bricker; M Fishman; O H Frazier; J K Price; B Radovancevic; P T Louis; A K Cabalka; B D Gelb; J A Towbin
Journal:  J Heart Lung Transplant       Date:  1992 Sep-Oct       Impact factor: 10.247

View more
  1 in total

1.  Electroretinographic findings in transplant chorioretinopathy.

Authors:  Brian T Chan-Kai; Steven Yeh; Richard G Weleber; Peter J Francis; Grazyna Adamus; S Robert Witherspoon; Andreas K Lauer
Journal:  Clin Ophthalmol       Date:  2010-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.